user

Total Car-T Cost of Care Beyond the Price of Car-T Cell Therapy in Patients with Multiple Myeloma

被引：7
|
作者：
Jagannath, Sundar [1 ]
Joseph, Nedra [2 ]
Crivera, Concetta [2 ]
Jackson, Carolyn C. [3 ]
Valluri, Satish [4 ]
Cost, Patricia [5 ]
Phelps, Hilary [4 ]
Slowik, Rafal [4 ]
Klein, Timothy [5 ]
Yu, Xueting [5 ]
Smolen, Lee [5 ]
Cohen, Adam D. [6 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Janssen Sci Affairs LLC, Horsham, PA USA
[3] Janssen R&D, Raritan, NJ USA
[4] Janssen Global Serv LLC, Raritan, NJ USA
[5] Med Decis Modeling Inc, Indianapolis, IN USA
[6] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4964
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Post CAR-T lymphocytosis as a surrogate of BCMA CAR-T expansion, response, and prognosis in multiple myeloma
    Saldarriaga, Mateo Mejia
    Pan, Darren
    Unkenholz, Caitlin
    Mouhieddine, Tarek
    Fein, Josh
    Monge, Jorge
    Rosenbaum, Cara
    Pearse, Roger
    Jayabalan, David
    Gordillo, Christian
    Chan, Hei Ton
    Mapara, Markus
    Inghirami, Giorgio
    Lentzsch, Suzanne
    Reshef, Ren
    Rossi, Adriana
    Parekh, Samir
    Jagannath, Sundar
    Richards, Shambavi
    Niesvizky, Ruben
    Bustoros, Mark
    CANCER RESEARCH, 2024, 84 (06)
  • [22] CAR-T cell therapy in Multiple Myeloma: current status and future challenges
    Swan, Dawn
    Madduri, Deepu
    Hocking, Jay
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [23] CAR-T cell therapy in relapsed or refractory multiple myeloma and access in Turkey
    Hakan, Goker
    Engin, Kelkitli
    Elifcan, Karakulak Aladag
    Haluk, Demiroglu
    Mehmet, Turgut
    Suman, Kambhampati
    Maxwell, Krem
    FRONTIERS IN MEDICINE, 2024, 11
  • [24] Biomarkers for CAR-T Cell Therapy
    不详
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 123 - 124
  • [25] Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
    Christopher T. Su
    J. Christine Ye
    Journal of Hematology & Oncology, 14
  • [26] Salvage Transplant Versus CAR-T Cell Therapy for Relapsed Multiple Myeloma
    Gagelmann, Nico
    Garderet, Laurent
    Iacobelli, Simona
    Koster, Linda
    Carotti, Alessandra
    Schoenland, Stefan
    Galieni, Piero
    Daskalakis, Michael
    Roeloffzen, Wilfried
    Hunter, Hannah
    Duchosal, Michel A.
    Lenhoff, Stig
    Arat, Mutlu
    Wulf, Gerald G.
    Bolam, Simon
    Pastore, Domenico
    Gedde-Dahl, Tobias
    Richardson, Deborah Susan
    Mielke, Stephan
    Raj, Kavita
    Drozd-Sokolowska, Joanna
    Hayden, Patrick John
    McLornan, Donal P.
    BLOOD, 2023, 142
  • [27] CAR-T cell therapy in multiple myeloma: Current limitations and potential strategies
    Zhang, Xiaomin
    Zhang, Hui
    Lan, Huixuan
    Wu, Jinming
    Xiao, Yang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [28] CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil
    Hungria, Vania
    Pierola, Ana Alfonso
    Schmidt Filho, Jayr
    Crusoe, Edvan
    de Magalhaes Filho, Roberto Jose Pessoa
    Maiolino, Angelo
    Rodriguez-Otero, Paula
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (02) : 266 - 274
  • [29] Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
    Su, Christopher T.
    Ye, J. Christine
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [30] CAR-T Cell Therapy for Lymphoma
    Ramos, Carlos A.
    Heslop, Helen E.
    Brenner, Malcolm K.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 165 - 183
12345